Elsevier
Cell Stem Cell
,  volume 21 ,  issue 2 ,  pages 166-177

Mesenchymal Stem Cells in Fibrotic Disease.

E. El Agha 1, 2
, 
Rafael Kramann 3
, 
Rebekka K. Schneider 4, 5
, 
Xiaokun Li 2
, 
WERNER SEEGER 1, 6
, 
Benjamin D. Humphreys 7
, 
Saverio Bellusci 1, 2
1
 
2
 
3
 
4
 
5
 
6
 
7
 
Publication type: Journal Article
Publication date: 2017-08-03
Elsevier
scimago Q1
wos Q1
SJR: 9.313
CiteScore: 32.9
Impact factor: 20.4
ISSN: 19345909, 18759777
Cell Biology
Genetics
Molecular Medicine
Abstract
Fibrosis is associated with organ failure and high mortality and is commonly characterized by aberrant myofibroblast accumulation. Investigating the cellular origin of myofibroblasts in various diseases is thus a promising strategy for developing targeted anti-fibrotic treatments. Recent studies using genetic lineage tracing technology have implicated diverse organ-resident perivascular mesenchymal stem cell (MSC)-like cells and bone marrow-MSCs in myofibroblast generation during fibrosis development. In this Review, we give an overview of the emerging role of MSCs and MSC-like cells in myofibroblast-mediated fibrotic disease in the kidney, lung, heart, liver, skin, and bone marrow.
Found 
Found 

Top-30

Journals

2
4
6
8
10
12
14
16
18
Stem Cell Research and Therapy
Stem Cell Research and Therapy, 17, 4.68%
Stem Cell Research and Therapy
17 publications, 4.68%
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology, 12, 3.31%
Frontiers in Cell and Developmental Biology
12 publications, 3.31%
Scientific Reports
Scientific Reports, 12, 3.31%
Scientific Reports
12 publications, 3.31%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 9, 2.48%
International Journal of Molecular Sciences
9 publications, 2.48%
Cells
Cells, 9, 2.48%
Cells
9 publications, 2.48%
Frontiers in Pharmacology
Frontiers in Pharmacology, 6, 1.65%
Frontiers in Pharmacology
6 publications, 1.65%
Stem Cells International
Stem Cells International, 6, 1.65%
Stem Cells International
6 publications, 1.65%
Nature Communications
Nature Communications, 5, 1.38%
Nature Communications
5 publications, 1.38%
Biomedicine and Pharmacotherapy
Biomedicine and Pharmacotherapy, 5, 1.38%
Biomedicine and Pharmacotherapy
5 publications, 1.38%
Current Stem Cell Research and Therapy
Current Stem Cell Research and Therapy, 4, 1.1%
Current Stem Cell Research and Therapy
4 publications, 1.1%
European Respiratory Journal
European Respiratory Journal, 4, 1.1%
European Respiratory Journal
4 publications, 1.1%
Stem cells translational medicine
Stem cells translational medicine, 4, 1.1%
Stem cells translational medicine
4 publications, 1.1%
World Journal of Stem Cells
World Journal of Stem Cells, 4, 1.1%
World Journal of Stem Cells
4 publications, 1.1%
Frontiers in Immunology
Frontiers in Immunology, 4, 1.1%
Frontiers in Immunology
4 publications, 1.1%
Cell Death and Disease
Cell Death and Disease, 4, 1.1%
Cell Death and Disease
4 publications, 1.1%
Stem Cell Reviews and Reports
Stem Cell Reviews and Reports, 4, 1.1%
Stem Cell Reviews and Reports
4 publications, 1.1%
American Journal of Physiology - Lung Cellular and Molecular Physiology
American Journal of Physiology - Lung Cellular and Molecular Physiology, 4, 1.1%
American Journal of Physiology - Lung Cellular and Molecular Physiology
4 publications, 1.1%
Science advances
Science advances, 3, 0.83%
Science advances
3 publications, 0.83%
JCI insight
JCI insight, 3, 0.83%
JCI insight
3 publications, 0.83%
Advanced Science
Advanced Science, 3, 0.83%
Advanced Science
3 publications, 0.83%
Pharmaceutics
Pharmaceutics, 3, 0.83%
Pharmaceutics
3 publications, 0.83%
International Immunopharmacology
International Immunopharmacology, 3, 0.83%
International Immunopharmacology
3 publications, 0.83%
Cell and Tissue Research
Cell and Tissue Research, 2, 0.55%
Cell and Tissue Research
2 publications, 0.55%
Journal of Clinical Investigation
Journal of Clinical Investigation, 2, 0.55%
Journal of Clinical Investigation
2 publications, 0.55%
Journal of Inflammation Research
Journal of Inflammation Research, 2, 0.55%
Journal of Inflammation Research
2 publications, 0.55%
Molecular Medicine Reports
Molecular Medicine Reports, 2, 0.55%
Molecular Medicine Reports
2 publications, 0.55%
Circulation Research
Circulation Research, 2, 0.55%
Circulation Research
2 publications, 0.55%
World Journal of Clinical Cases
World Journal of Clinical Cases, 2, 0.55%
World Journal of Clinical Cases
2 publications, 0.55%
Frontiers in Molecular Biosciences
Frontiers in Molecular Biosciences, 2, 0.55%
Frontiers in Molecular Biosciences
2 publications, 0.55%
2
4
6
8
10
12
14
16
18

Publishers

10
20
30
40
50
60
70
80
90
Springer Nature
Springer Nature, 87, 23.97%
Springer Nature
87 publications, 23.97%
Elsevier
Elsevier, 60, 16.53%
Elsevier
60 publications, 16.53%
Wiley
Wiley, 34, 9.37%
Wiley
34 publications, 9.37%
MDPI
MDPI, 32, 8.82%
MDPI
32 publications, 8.82%
Frontiers Media S.A.
Frontiers Media S.A., 30, 8.26%
Frontiers Media S.A.
30 publications, 8.26%
Taylor & Francis
Taylor & Francis, 12, 3.31%
Taylor & Francis
12 publications, 3.31%
Cold Spring Harbor Laboratory
Cold Spring Harbor Laboratory, 12, 3.31%
Cold Spring Harbor Laboratory
12 publications, 3.31%
Hindawi Limited
Hindawi Limited, 8, 2.2%
Hindawi Limited
8 publications, 2.2%
Bentham Science Publishers Ltd.
Bentham Science Publishers Ltd., 7, 1.93%
Bentham Science Publishers Ltd.
7 publications, 1.93%
Baishideng Publishing Group
Baishideng Publishing Group, 7, 1.93%
Baishideng Publishing Group
7 publications, 1.93%
American Society for Clinical Investigation
American Society for Clinical Investigation, 5, 1.38%
American Society for Clinical Investigation
5 publications, 1.38%
European Respiratory Society (ERS)
European Respiratory Society (ERS), 5, 1.38%
European Respiratory Society (ERS)
5 publications, 1.38%
Oxford University Press
Oxford University Press, 5, 1.38%
Oxford University Press
5 publications, 1.38%
American Chemical Society (ACS)
American Chemical Society (ACS), 4, 1.1%
American Chemical Society (ACS)
4 publications, 1.1%
American Society of Hematology
American Society of Hematology, 4, 1.1%
American Society of Hematology
4 publications, 1.1%
American Physiological Society
American Physiological Society, 4, 1.1%
American Physiological Society
4 publications, 1.1%
American Association for the Advancement of Science (AAAS)
American Association for the Advancement of Science (AAAS), 3, 0.83%
American Association for the Advancement of Science (AAAS)
3 publications, 0.83%
Mary Ann Liebert
Mary Ann Liebert, 3, 0.83%
Mary Ann Liebert
3 publications, 0.83%
Spandidos Publications
Spandidos Publications, 3, 0.83%
Spandidos Publications
3 publications, 0.83%
Ovid Technologies (Wolters Kluwer Health)
Ovid Technologies (Wolters Kluwer Health), 3, 0.83%
Ovid Technologies (Wolters Kluwer Health)
3 publications, 0.83%
SAGE
SAGE, 3, 0.83%
SAGE
3 publications, 0.83%
S. Karger AG
S. Karger AG, 2, 0.55%
S. Karger AG
2 publications, 0.55%
Higher Education Press
Higher Education Press, 2, 0.55%
Higher Education Press
2 publications, 0.55%
Social Science Electronic Publishing
Social Science Electronic Publishing, 2, 0.55%
Social Science Electronic Publishing
2 publications, 0.55%
Federation of American Societies for Experimental Biology (FASEB)
Federation of American Societies for Experimental Biology (FASEB), 2, 0.55%
Federation of American Societies for Experimental Biology (FASEB)
2 publications, 0.55%
AME Publishing Company
AME Publishing Company, 2, 0.55%
AME Publishing Company
2 publications, 0.55%
The Company of Biologists
The Company of Biologists, 1, 0.28%
The Company of Biologists
1 publication, 0.28%
F1000 Research
F1000 Research, 1, 0.28%
F1000 Research
1 publication, 0.28%
World Scientific
World Scientific, 1, 0.28%
World Scientific
1 publication, 0.28%
10
20
30
40
50
60
70
80
90
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
363
Share
Cite this
GOST |
Cite this
GOST Copy
El Agha E. et al. Mesenchymal Stem Cells in Fibrotic Disease. // Cell Stem Cell. 2017. Vol. 21. No. 2. pp. 166-177.
GOST all authors (up to 50) Copy
El Agha E., Kramann R., Schneider R. K., Li X., SEEGER W., Humphreys B. D., Bellusci S. Mesenchymal Stem Cells in Fibrotic Disease. // Cell Stem Cell. 2017. Vol. 21. No. 2. pp. 166-177.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.stem.2017.07.011
UR - https://doi.org/10.1016/j.stem.2017.07.011
TI - Mesenchymal Stem Cells in Fibrotic Disease.
T2 - Cell Stem Cell
AU - El Agha, E.
AU - Kramann, Rafael
AU - Schneider, Rebekka K.
AU - Li, Xiaokun
AU - SEEGER, WERNER
AU - Humphreys, Benjamin D.
AU - Bellusci, Saverio
PY - 2017
DA - 2017/08/03
PB - Elsevier
SP - 166-177
IS - 2
VL - 21
PMID - 28777943
SN - 1934-5909
SN - 1875-9777
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2017_El Agha,
author = {E. El Agha and Rafael Kramann and Rebekka K. Schneider and Xiaokun Li and WERNER SEEGER and Benjamin D. Humphreys and Saverio Bellusci},
title = {Mesenchymal Stem Cells in Fibrotic Disease.},
journal = {Cell Stem Cell},
year = {2017},
volume = {21},
publisher = {Elsevier},
month = {aug},
url = {https://doi.org/10.1016/j.stem.2017.07.011},
number = {2},
pages = {166--177},
doi = {10.1016/j.stem.2017.07.011}
}
MLA
Cite this
MLA Copy
El Agha, E., et al. “Mesenchymal Stem Cells in Fibrotic Disease..” Cell Stem Cell, vol. 21, no. 2, Aug. 2017, pp. 166-177. https://doi.org/10.1016/j.stem.2017.07.011.